96 related articles for article (PubMed ID: 25572108)
1. Hepatic adrenal rest tumor: Diagnostic pitfall and proposed algorithms to prevent misdiagnosis as lipid-rich hepatocellular carcinoma.
Sugiyama T; Tajiri T; Hiraiwa S; Inomoto C; Kajiwara H; Kojima S; Tobita K; Nakamura N
Pathol Int; 2015 Feb; 65(2):95-9. PubMed ID: 25572108
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma.
Nguyen T; Phillips D; Jain D; Torbenson M; Wu TT; Yeh MM; Kakar S
Arch Pathol Lab Med; 2015 Aug; 139(8):1028-34. PubMed ID: 26230595
[TBL] [Abstract][Full Text] [Related]
3. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
4. Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study.
Zhang L; Liu H; Sun L; Li N; Ding H; Zheng J
Acta Histochem; 2012 Oct; 114(6):547-52. PubMed ID: 22119409
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors.
Gonzalez-Roibon N; Katz B; Chaux A; Sharma R; Munari E; Faraj SF; Illei PB; Torbenson M; Netto GJ
Hum Pathol; 2013 Jul; 44(7):1293-9. PubMed ID: 23347651
[TBL] [Abstract][Full Text] [Related]
6. Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction.
Sempoux C; Fan C; Singh P; Obeidat K; Roayaie S; Schwartz M; Fiel MI; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):104-10. PubMed ID: 21344355
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
Lin F; Abdallah H; Meschter S
Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].
Dong H; Cong WL; Zhu ZZ; Wang B; Xian ZH; Yu H
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):702-5. PubMed ID: 19173916
[TBL] [Abstract][Full Text] [Related]
9. Adrenal Rest Tumor of the Liver Preoperatively Diagnosed as Hepatocellular Carcinoma.
Enjoji M; Sanada K; Seki R; Ito T; Maeda M
Case Rep Surg; 2017; 2017():8231943. PubMed ID: 28706747
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Lei JY; Bourne PA; diSant'Agnese PA; Huang J
Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
[TBL] [Abstract][Full Text] [Related]
11. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
Nassar A; Cohen C; Siddiqui MT
Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
[TBL] [Abstract][Full Text] [Related]
12. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions.
Enan ET; El-Hawary AK; El-Tantawy DA; Abu-Hashim MM; Helal NM
Ann Diagn Pathol; 2013 Dec; 17(6):490-3. PubMed ID: 24012547
[TBL] [Abstract][Full Text] [Related]
14. [A case of pedunculated hepatoma suspected of adrenal tumor].
Hanai T; Miyatake R; Hashimoto K; Kato Y; Iguchi M
Hinyokika Kiyo; 1999 Jun; 45(6):411-3. PubMed ID: 10442283
[TBL] [Abstract][Full Text] [Related]
15. [Pedunculated hepatocellular carcinoma suspected of right adrenal tumor: a case report].
Kawamoto K; Noguchi S; Sakai N; Sakuramoto T; Syuin T; Noguchi K; Kinoshita Y; Kubota Y; Hosaka M
Hinyokika Kiyo; 1992 Aug; 38(8):929-32. PubMed ID: 1329450
[TBL] [Abstract][Full Text] [Related]
16. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
17. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
Geramizadeh B; Boub R; Rahsaz M
Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy.
Gonzalez SA; Keeffe EB
Clin Liver Dis; 2011 May; 15(2):297-306, vii-x. PubMed ID: 21689614
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma of unknown primary: check the liver... thanks to TTF-1.
Mishra M; Morgan V; Hamati AK; Al-Abbadi M
Tenn Med; 2012 Jan; 105(1):35-6, 40. PubMed ID: 22359993
[TBL] [Abstract][Full Text] [Related]
20. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
Hanif R; Mansoor S
J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
